Loading...
The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
The management of RA, SpA, psoriasis and inflammatory bowel disease has significantly improved over the last decade with the addition of tumour necrosis factor inhibitors (anti-TNFs) to the therapeutic armamentarium. Immunogenicity in response to monoclonal antibody therapies (anti-drug antibodies)...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3894670/ https://ncbi.nlm.nih.gov/pubmed/23946436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/ket260 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|